Overview


The Pharmaceutical Spray Drying Market involves technologies that convert liquid drugs into stable, dry powders to improve solubility, bioavailability, and targeted delivery. The market is growing due to demand for advanced drug formulations, biologics, and innovative particle engineering solutions.

According to FutureWise analysis, the Pharmaceutical Spray Drying Market in 2026 is US$2.52 billion and is expected to reach US$4.96 billion by 2036, at a CAGR of 7.01%. The pharmaceutical spray-drying market is experiencing growth driven by several key factors. There is increasing demand for inhalable drugs, rising adoption of advanced drug-delivery systems, and expansion of the biopharmaceutical sector. Additionally, the trend toward personalized medicine and the development of high-value biologics are further enhancing market demand.

Growth Drivers:

  • Rising demand for stable and soluble drug formulations.
  • Growing use of biologics and vaccines requiring precise particle control.
  • Increasing adoption of advanced spray drying technologies in pharma manufacturing.
  • Expansion of contract development and manufacturing organizations (CDMOs).
  • Focus on controlled drug release and targeted delivery systems.

Key Trends:

  • Increasing use of spray drying for biologics and peptide drugs.
  • Adoption of continuous manufacturing and process automation.
  • Growing focus on particle engineering for improved drug delivery.
  • Expansion of CDMO partnerships for specialized spray drying services.
  • Integration of advanced analytics and quality-by-design (QbD) approaches.

Market Segmentation and Key Players:

The Pharmaceutical Spray Drying Market is segmented by product type (rotary, nozzle, fluidized, and centrifugal systems), application (excipient production, encapsulation, and dry powder inhalers), and region (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa). This structure helps stakeholders address specific needs in drug formulation, particle engineering, and inhalable therapies. Comprehensive segmentation details are provided in the Segmentation section below.

Major companies operating in the Pharmaceutical Spray Drying Market include Catalent, Inc., Hovione, and GEA Group.

Research Methodology:

The Pharmaceutical Spray Drying Market report by FutureWise Research utilizes a structured methodology that combines secondary data from industry sources and company reports with primary research from industry experts. This involves market sizing, data triangulation, and validation to assess current values and forecast trends across product types, applications, and regions, ensuring a comprehensive analysis of drivers, restraints, opportunities, and competitive dynamics for strategic decision-making.

  • Albany Molecular Research Inc.
  • Catalent, Inc
  • Thermo Fisher Scientific Inc.
  • Hovione
  • Fuji Chemical Industry Co., Ltd
  • Nova Laboratories
  • Janssen Global Services, LLC
  • Zambon Company S.P.A.
  • GlaxoSmithKline plc.
  • Novartis AG
  • Wuxi AppTec.

(Note: The list of major players will be updated with the latest market scenario and trends)

Recent developments by key players in the Pharmaceutical Spray Drying Market:

Catalent, Inc.

  • Expansion of Spray Drying Capacity: In 2024, Catalent upgraded its large-scale spray drying capabilities at its Boston facility by implementing an advanced spray drying system. This enhancement allows for improved support during late-stage clinical trials and the commercialization of amorphous solid dispersion (ASD) formulations.
  • Addition of Inhaled Dry Powder Capabilities: Catalent has enhanced its capabilities for inhaled dry powders by incorporating potent capsule filling. This positions the company as a leading CDMO with substantial GMP capacity for both capsule spray-dried and carrier-based inhaled powders.

Wuxi AppTec.

  • In July 2025, WuXi STA launched a new PSD-4 spray dryer at its Taixing API manufacturing facility in China, enhancing its spray-dried dispersion capabilities to support solid-dosage development and improve API solubility and formulation performance.
  • In April 2025, both the Changzhou and Taixing API sites successfully passed FDA inspections, reinforcing confidence in their global GMP compliance for spray drying and related drug substance manufacturing.

Hovione

  • In February 2022, Hovione formed a strategic partnership with Zerion Pharma to commercialize its Dispersome technology. This technology enhances drug solubility by spray-drying active pharmaceutical ingredients into amorphous solid dispersions, thus supporting formulation innovation.
  • In late 2023, Hovione participated in a GEA seminar that focused on spray drying techniques in biologics, inhalation therapies, and formulation strategies driven by process efficiency.

Fuji Chemical Industry Co., Ltd

  • Fuji Chemical is a long-established leader in pharmaceutical spray drying. The company specializes in contract spray-drying services and high-performance excipients, including Neusilin, Fujicalin, and F-MELT. These excipients are designed using proprietary crystalline control and particle design technologies. Their functionalities effectively address challenges related to solubility, flow, and compression in oral drug formulations.
  • Fuji operates both closed-cycle spray dryers for high-potency drugs and open-cycle units while maintaining cGMP compliance. Recently, they completed the construction of high-containment spray drying facilities to support solid dispersion and high-potency API work.

Due to the significant decline in production processes and the constrained demand and supply of medications, the early stages of the pandemic had a profoundly negative impact on the growth of the pharmaceutical spray drying industry. The COVID-19 pandemic has caused a shortage of active pharmaceutical ingredients, according to the governments of various nations. The COVID-19 pandemic also led to a significant increase in medicine prices in 2021, resulting from increased demand for medications to treat various illnesses, including HIV, cancer, epilepsy, and malaria, according to the Pharmaceutical Export Promotion Council (PHARMEXCIL). Thus, the market first experienced a negative effect. However, the recovery from the shortage and the rising use of pharmaceutical spray drying for COVID-19 drugs, drug application, and vaccines have positively impacted the market. As a result, the market experienced significant growth during the later phase of the pandemic and is anticipated to continue expanding over the forecast period. The benefits of spray drying include quick drying times, adaptability, compatibility for heat-sensitive items, and simplicity in maintaining product quality. The pharmaceutical spray drying market is expected to grow as a result of several key factors, including the expansion of the pharmaceutical industry, an increase in disease prevalence worldwide, government infrastructure support, technological advancements in drug production, improved product stability, and increased R&D spending globally. The global pharmaceutical spray drying market is anticipated to grow over the projected period as a result of government initiatives to commercialise spray drying technologies and rising adoption of spray drying in emerging nations. The market for pharmaceutical spray drying, however, is projected to have growth restraints due to high spray drying costs. The pharmaceutical spray drying industry is anticipated to benefit from the launch of novel medications such as vaccines and biologics that need spray drying technology to produce. Enhanced product stability and high efficiency are two characteristics that are driving the pharmaceutical spray drying market.

By Product Type

  • Rotary Atomizer
  • Nozzle Atomizer
  • Fluidized
  • Centrifugal

By Application

  • Excipient Production
  • Encapsulation
  • Enhancing Bioavailability
  • Dry Powder Inhalers
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasizes factors affecting the growth rate in the various regions listed above. A deep-down analysis of the region will also be provided in the final version of this market, which is based on the conclusion of primary interviews and secondary data points gathered during the process.

Here’s a regional view of where the most progress is happening

North America

  • High concentration of key market players: Companies such as Catalent, Thermo Fisher Scientific, Lonza, and Hovione operate major facilities and R&D centers in the U.S., contributing to technological advancements.
  • Robust pharmaceutical and biotech ecosystem: The United States and Canada possess robust regulatory frameworks, advanced manufacturing infrastructure, and a high rate of adoption of innovative drug delivery technologies.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. Due to factors like the presence of significant pharmaceutical businesses, the high demand for pharmaceutical goods, technical advancements, and the high level of pharmaceutical R&D spending in the region. The market's growth is projected to be boosted by the rising company focus on expansion and the adoption of business strategies to maintain its position in the industry. For instance, Eurofins (Contract Development and Manufacturing Organization) stated in January 2022 that its current spray dry development and production services would be extended to North America. With this growth, Eurofins will be able to better complement its wide variety of services that focus on improving solubility for clinical research and small-scale commercial projects. Some of the key driving factors anticipated to propel the US pharmaceutical spray drying market over the projected period include the rising prevalence of chronic diseases and rising investments in pharmaceutical research & development activities.


  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Pharmaceutical Spray Drying Market By Product Type, By Application and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  •  We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com.

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Pharmaceutical Spray Drying Market Variables, Trends and Scope
    •        1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Pharmaceutical Spray Drying Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Pharmaceutical Spray Drying Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Pharmaceutical Spray Drying Market, By Product Type Historical Analysis and Forecast 2026-2036 (USD Million)
    •   1. Rotary Atomizer
        2. Nozzle Atomizer
        3. Fluidized
        4. Centrifugal

  • 8.   Pharmaceutical Spray Drying Market, By Application Historical Analysis and Forecast 2026-2036 (USD Million)
    •   1. Excipient Production
        2. Encapsulation
        3. Enhancing Bioavailability
        4. DryPowder Inhalers
        5. Other

  • 9.   North America Pharmaceutical Spray Drying Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2026-2036

  • 10.   Latin America Pharmaceutical Spray Drying Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2026-2036

  • 11.   Europe Pharmaceutical Spray Drying Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2026-2036

  • 12.   Asia Pacific Pharmaceutical Spray Drying Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2026-2036

  • 13.   Middle East and Africa Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2026-2036

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Albany Molecular Research Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Catalent, Inc.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Thermo Fisher Scientific Inc.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Hovione
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Fuji Chemical Industry Co., Ltd.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Nova Laboratories
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Janssen Global Services, LLC.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Zambon Company S.P.A.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. GlaxoSmithKline plc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Novartis AG
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Wuxi AppTec.
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 17.   FutureWise SME Key Takeaway Points for Client

FAQ


Pharmaceutical spray drying is a process that transforms liquid solutions, suspensions, or emulsions into dry powder by quickly drying them with hot gas. This technique is commonly employed to enhance drug solubility, stability, and bioavailability.
 

  • Oral solid dosage forms
  • Inhalable drugs (dry powder inhalers)
  • Biologics and vaccines
  • Controlled-release formulations
  • Nutraceuticals and high-potency compounds
     

North America is at the forefront due to its robust pharmaceutical infrastructure, significant investment in R&D, and the presence of major industry players. Europe closely follows, especially in countries such as Ireland, Germany, and Switzerland.
 

Related Market

Dietary Supplements Spray Drying Market

Read More

Pharmaceutical Water Market

Read More

Pharmaceutical Fill and Finish Outsourcing Market

Read More
Partner

Our Clients